Regulatory T cells in kidney transplant recipients: The effect of induction immunosuppression therapy

Nephrology Dialysis Transplantation

Volumn 27, Issue 6, 2012, Pages 2576-2582

  Krystufkova, Eva ^a   Sekerkova, Alena ^a   Striz, Ilja ^a   Brabcova, Irena ^a   Girmanova, Eva ^a   Viklicky, Ondrej ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Basiliximab; FoxP3; Kidney transplantation; RATG; Regulatory T cells

Indexed keywords

BASILIXIMAB; CD4 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; L SELECTIN; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CORRELATION ANALYSIS; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84861907996     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr693     Document Type: Article

References (27)

1. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009; 9 (Suppl 3): S1-S155
2. Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164
3. Lopez M, Clarkson MR, Albin M et al. A novel mechanism of action for anti-thymocyte globulin: induction of CD41CD251Foxp31 regulatory T cells. J Am Soc Nephrol 2006; 17: 2844-2853
4. Sadlack B, Merz H, Schorle H et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-261
5. Malek TR, Yu A, Vincek V et al. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17: 167-178
6. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-210
7. Braudeau C, Racape M, Giral M et al. Variation in numbers of CD41CD25highFOXP31 T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 2007; 20: 845-855
8. Zheng XX, Sanchez-Fueyo A, Domenig C et al. The balance of deletion and regulation in allograft tolerance. Immunol Rev 2003; 196: 75-84
9. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526
10. Thibaudin D, Alamartine E, de Filippis JP et al. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin. Nephrol Dial Transplant 1998; 13: 711-715
11. Sewgobind VD, Kho MM, van der Laan LJ et al. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients. Nephrol Dial Transplant 2009; 24: 1635-1644
12. Sewgobind VD, van der Laan LJ, Kho MM et al. Characterization of rabbit antithymocyte globulins-induced CD251 regulatory T cells from cells of patients with end-stage renal disease. Transplantation 2010; 89: 655-666
13. Gurkan S, Luan Y, Dhillon N et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant 2010; 10: 2132-2141
14. Feng X, Kajigaya S, Solomou EE et al. Rabbit ATG but not horse ATG promotes expansion of functional CD41CD25highFOXP31 regulatory T cells in vitro. Blood 2008; 111: 3675-3683
15. Lowsky R, Takahashi T, Liu YP et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005; 353: 1321-1331
16. Wang Z, Shi BY, Qian YY et al. Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation. Clin Exp Immunol 2009; 155: 496-503
17. Vondran FW, Timrott K, Tross J et al. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation. Transpl Int 2010; 23: 514-523
18. Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD41CD25-naive T cells to CD41CD251 regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886
19. de Goer de Herve MG, Gonzales E, Hendel-Chavez H et al. CD25 appears non essential for human peripheral T(reg) maintenance in vivo. PLoS One 2010; 5: e11784
20. Vincenti F, Lantz M, Birnbaum J et al. A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation. Transplantation 1997; 63: 33-38
21. Abadja F, Alamartine E, Berthoux F et al. Quantification of circulating regulatory T cells by flow cytometry in kidney transplant patients after basiliximab induction therapy. Transplantation 2010; 89: 366-368
22. Viklicky O, Hribova P, Volk HD et al. Molecular phenotypes of acute rejection predict kidney graft prognosis. J Am Soc Nephrol 2010; 21: 173-180
23. Halloran PF, de Freitas DG, Einecke G et al. The molecular phenotype of kidney transplants. Am J Transplant 2010; 10: 2215-2222
24. Moxham VF, Karegli J, Phillips RE et al. Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol 2008; 180: 3910-3918
25. Egawa H, Ozawa K, Takada Y et al. Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. Dig Dis Sci 2009; 54: 2253-2263
26. Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD41 T reg cells. J Exp Med 2006; 203: 1701-1711
27. Klein S, Kretz CC, Krammer PH et al. CD127(low/-) and FoxP3(1) expression levels characterize different regulatory T-cell populations in human peripheral blood. J Invest Dermatol 2010; 130: 492-499